Figure 1.
(A) Study methods schematic according to the two basic aims: (a) cSS progression prevalence and predictors between baseline and follow-up MRI (i.e. MRI follow-up period); (b) incident first-ever lobar ICH risk during clinical follow-up (i.e. clinical follow-up period) in relation to cSS progression, in stroke-free CAA patients during the MRI follow-up period. (B) Flow chart of patient selection.